Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr955 Inhibitors

Olfr955, a member of the olfactory receptor family 1 subfamily K, is integral to the olfactory system in Mus musculus, functioning as a G-protein-coupled receptor (GPCR). These receptors are essential for the detection and transduction of odorant signals, leading to the perception of smell. Olfr955, characterized by a 7-transmembrane domain structure, binds to specific odorant molecules, triggering a cascade of intracellular events leading to neuronal responses. This process is vital to the olfactory system's ability to detect and differentiate a wide range of scents, underscoring the significance of Olfr955 in the sense of smell. Inhibiting the function of Olfr955 involves complex molecular interactions. Direct inhibition would typically entail obstructing the receptor's interaction with odorant molecules, preventing G-protein activation and subsequent signal transduction. This approach requires precise molecular specificity to avoid impacting other GPCRs. Indirect inhibition strategies encompass a broader range, including modifying the receptor's membrane environment or influencing downstream signaling pathways. Altering membrane composition or receptor conformation can impact Olfr955's ability to bind odorants or transduce signals. Additionally, targeting signaling pathways that regulate receptor desensitization, internalization, or recycling can modulate its activity. The chemicals listed in the table exemplify potential indirect inhibitors of Olfr955, acting through various mechanisms such as cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, or alteration of G-protein coupling efficiency.

Understanding the mechanisms governing Olfr955's function and inhibition is pivotal for decoding the complex dynamics of olfactory transduction. Exploring both direct and indirect inhibitory strategies sheds light on the modulation of GPCR activity, particularly in the context of olfactory receptors. This knowledge not only advances our understanding of olfactory perception but also contributes to the broader field of GPCR research, which has significant implications in sensory biology and pharmacology. The study of inhibitors of Olfr955 and similar receptors is crucial for developing a comprehensive understanding of the molecular dynamics governing olfactory signaling and the potential for targeted modulation of these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Posaconazole

171228-49-2sc-212571
1 mg
$353.00
7
(1)

Posaconazole, an antifungal agent, inhibits cytochrome P450 enzymes, affecting steroid biosynthesis. This may alter GPCR function, including olfactory receptors like Olfr955, by changing membrane lipid composition and receptor conformation.

(R)-Cetirizine Dihydrochloride

130018-77-8sc-212682
10 mg
$300.00
(0)

(R)-Cetirizine Dihydrochloride, a selective H1 antihistamine, indirectly modulates GPCR signaling. By inhibiting histamine action, it reduces the modulation of GPCR activity, potentially decreasing Olfr955 signaling in olfactory pathways.

Bisoprolol

66722-44-9sc-278792
25 mg
$204.00
(0)

Bisoprolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr955 function.

Olanzapine

132539-06-1sc-212469
100 mg
$130.00
6
(1)

Olanzapine, an atypical antipsychotic, acts on various neurotransmitter receptors, including GPCRs. Its broad receptor interaction profile can lead to modulation of GPCR pathways, indirectly affecting Olfr955 activity in olfaction.

Betaxolol

63659-18-7sc-210913
10 mg
$212.00
1
(1)

Betaxolol, a selective beta-1 adrenergic receptor blocker, modulates GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr955 function.

Rabeprazole

117976-89-3sc-204872
sc-204872A
10 mg
25 mg
$342.00
$608.00
2
(1)

Rabeprazole, a proton pump inhibitor, can indirectly modulate GPCR activity. By influencing gastric acid secretion, it impacts the histamine-mediated modulation of GPCRs, potentially affecting Olfr955 signaling.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol, a non-selective beta-adrenergic receptor blocker, modulates GPCR signaling pathways indirectly. Its action on beta receptors can affect G-protein coupling in related GPCRs, potentially impacting Olfr955.

Amlodipine

88150-42-9sc-200195
sc-200195A
100 mg
1 g
$73.00
$163.00
2
(1)

Amlodipine, a calcium channel blocker, can influence GPCR function indirectly. By modulating calcium influx, it affects GPCR-mediated signaling, potentially impacting receptors like Olfr955.